by Bruce Sylvester – In the FIRE 3 trial, clinicians favored the use of second-line antibodies in patients with KRAS wild-type metastatic colorectal cancer (mCRC) with shorter first-line progression free… read more.
by Bruce Sylvester – KRAS exon 2 mutations are independent predictors of time to recurrence or disease-free survival among patients with stage III distal colon cancer who are receiving… read more.
by Bruce Sylvester – Metastatic colorectal cancer patients who achieved early response to first-line chemotherapy also achieved significantly higher rates of prolonged survival, compared to patients who did… read more.
by Bruce Sylvester – Survival based on primary site of disease is not significantly different among metastatic colorectal cancer patients, Australian researchers reported in a poster presentation at… read more.
Adapted from Abstract 3506, which was submitted to ASCO Congress 2014 Treatment outcome according to tumour RAS mutation status in CRYSTAL study patients with metastatic colorectal cancer (mCRC) randomized… read more.
World Health Matters by Gary Finnegan – Italy – Death rates from pancreatic cancer are predicted to increase in men and women in 2014 and beyond, according to… read more.
by Thomas R. Collins – A retrospective study of over 224,000 patients who underwent over 314,000 colonoscopies indicates that pre-cancerous adenoma detection tracks the future risk of colorectal… read more.
Practising sport for more than an hour day reduces the risk of contracting breast cancer, and this applies to women of any age and any weight, and also… read more.
by Thomas R. Collins: Women who are diagnosed with early stage breast cancer who also carry a mutation on the BRCA breast cancer gene are less likely to… read more.
Abstract: Flow cytometry (FCM) is more sensitive than conventional cytology for detection of occult leptomeningeal lymphoma; however, some FCM-negative patients show central nervous system (CNS) recurrence.
University of Utah researcher Eric Garland (pictured) developed a new mindfulness-focused treatment for people with chronic pain that can effectively reduce pain and misuse of opioid painkillers.
Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated. Investigators have reported more encouraging news about one of the most exciting methods… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
